Filing Details
- Accession Number:
- 0000905148-24-002519
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-05 16:13:20
- Reporting Period:
- 2024-09-03
- Accepted Time:
- 2024-09-05 16:13:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1704292 | Zai Lab Ltd | ZLAB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1741284 | Richard Gaynor | C/O Zai Lab Limited 314 Main Street, 4Th Floor, Suite 100 Cambridge MA 02142 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Disposition | 2024-09-03 | 2,500 | $19.50 | 46,568 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2024.
Billionaire Hedge Funds
